The Anti-Müllerian Hormone (AMH) plays a crucial role in regulating the reproductive function of both men and women, although its roles vary between genders. In women, AMH is produced by small ovarian follicles containing immature eggs.
Its primary function is inhibiting the development of Mullerian ducts, embryonic structures that eventually form female internal reproductive organs such as the uterus and fallopian tubes.
During embryonic development in females, AMH prevents Mullerian ducts from fully developing, allowing the appropriate formation of female reproductive structures. As girls reach puberty, AMH levels gradually decrease, triggering the development of internal reproductive organs and the onset of menstruation.
One of the most significant applications of AMH in reproductive medicine is assessing ovarian reserve, AMH levels can also offer insights into the proximity of menopause. As a woman ages and ovarian reserve naturally depletes, AMH levels decrease. This gradual decline can serve as a hint for women about the approach to menopause.
In assisted reproductive treatments, AMH levels are closely monitored to tailor ovarian stimulation strategies. A specialized physician can use AMH levels, along with other factors such as age and the patient’s medical history, to determine the appropriate dosage of medications, thus enhancing the chances of success in treatments like IVF.
In summary, Anti-Mullerian Hormone is a key component in evaluating ovarian reserve and planning fertility treatments. Its measurement and análisis provide a comprehensive insight into a woman’s reproductive capacity, enabling informed.
コメント